E89.82 Category · further specificity required Postprocedural hematoma and seroma of an endocrine system organ or structure
ICD-10-CM E89.82 identifies “Postprocedural hematoma and seroma of an endocrine system organ or structure” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
No additional notes.
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E89 · Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified
More specific codes
E89.820Postprocedural hematoma of an endocrine system organ or structure following an endocrine system procedureBillable / specificE89.821Postprocedural hematoma of an endocrine system organ or structure following other procedureBillable / specificE89.822Postprocedural seroma of an endocrine system organ or structure following an endocrine system procedureBillable / specificE89.823Postprocedural seroma of an endocrine system organ or structure following other procedureBillable / specificOfficial index references
History
Code history
Latest recorded change · FY2017
Effective from
- Added
Postprocedural hematoma and seroma of an endocrine system organ or structure
Category — select a more specific code
CDC/NCHS · FY2017All editions (18)
| All editions | Effective from | Code history |
|---|---|---|
| FY2017 | 2016-10-01 | Added |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.